Get the Stockscreener App
0.92
2.88%
-0.0273
After Hours:
.90
-0.02
-2.17%
Canopy Growth Corporation stock is traded at $0.92, with a volume of 4.19M.
It is down -2.88% in the last 24 hours and down -26.40% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$0.9473
Open:
$0.9351
24h Volume:
4.19M
Relative Volume:
0.55
Market Cap:
$143.71M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.1348
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
-6.66%
1M Performance:
-26.40%
6M Performance:
-79.19%
1Y Performance:
-90.59%
1-Day Range:
$0.8301
$0.94
1-Week Range:
$0.8301
$1.06
52-Week Range:
$0.8301
$14.92
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
0.92 | 143.71M | 211.87M | -551.61M | -140.45M | -6.8241 |
|
ZTS
Zoetis Inc
|
151.73 | 67.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 46.50B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.89 | 44.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.80 | 15.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.46 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Investor Alert: Robbins LLP Informs Stockholders of the Canopy Growth Corporation Class Action - PR Newswire
Canopy Growth ($CGC) Misleading Cost Efficiency and Product Rollout Case - TradingView
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations - Benzinga
2 cannabis stocks to sell, 1 contrarian to buy: Tilray, Canopy Growth, Curaleaf - Invezz
High just got higher: Trump tariffs to raise prices for US cannabis users - MarketScreener
Canopy Growth director sells shares worth $2,763 - Investing.com
What You Can Learn From Canopy Growth Corporation's (TSE:WEED) P/S After Its 28% Share Price Crash - simplywall.st
TLRY Stock: What to Look for in Tilray’s Q3 Earnings - CMC Markets
Canopy Growth Launches Spectrum Reserve: A New Premium Medical Cannabis Brand - TipRanks
Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand - Canopy Growth
New Premium Cannabis Hits Medical Market: Canopy's 30% THC Strains Set Industry Standard - Stock Titan
Better Buy: XRP vs Bitcoin - The Globe and Mail
Stocks In Play: Canopy Growth Corporation - Barchart.com
Canopy Growth Reduces Debt with Early Loan Prepayment - TipRanks
Canopy Growth reduces annual interest expense by $13 million (CGC:NASDAQ) - Seeking Alpha
Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million - Bluefield Daily Telegraph
Canopy Growth Slashes $100M Debt at Discount, Secures $13M Annual Savings - Stock Titan
From Trading to Checking Accounts: Robinhood's Big Bet on Banking - The Globe and Mail
Grown Rogue secures US$7M credit line for expansion initiatives - Mugglehead Magazine
Canopy Growth price target lowered to C$1.40 from C$1.70 at BofA - TipRanks
Cannabis Investors Should Sell Canopy Growth (NASDAQ:CGC) - Seeking Alpha
Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now? - MSN
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More - Benzinga
Is Canopy Growth Corporation’s (CGC) the Best Cannabis Stock to Buy According to Billionaires? - Yahoo Finance
10 Best Cannabis Stocks to Buy According to Billionaires - Insider Monkey
What Sparked The Cannabis Stock Rally On Thursday? - Benzinga
Canopy Growth's Future Hinges On US Cannabis Regulatory Shifts, Says Analyst, Issuing 'Neutral' Rating - Benzinga
This Roper Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Zuanic & Associates Initiates Coverage of Canopy Growth (CGC) with Neutral Recommendation - Nasdaq
Best Cannabis Stocks To Keep An Eye OnMarch 25th - MarketBeat
Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife? - Yahoo Canada Finance
Aurora Cannabis Rides the Global Legalization Wave: Should You Invest? - TradingView
Martha Stewart Aligns with Canopy Growth in New CBD Partnership - Investopedia
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Wana Brands Brings Hemp-Derived THC Edibles to Texas - Quantisnow
Major Cannabis Expansion: Wana Brands Brings Hemp THC Products to 22nd State Market - StockTitan
Why Canopy Growth Stock Jumped 16% on Wednesday - MSN
Cannabis Stocks To Keep An Eye On – March 13th - Defense World
Contra Guys: Pot stocks are getting closer to a buybut only some - The Globe and Mail
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Canopy Growth Announces Entry of Tweed Brand to German Medical C - GuruFocus.com
Major Retail Breakthrough: Wana Brands THC Drinks Hit Total Wine Shelves Across USA - StockTitan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Canopy Growth Corporation.CGC - cnhinews.com
Canopy Growth Expands Deep Space Propulsion Beverage Lineup with Two New Flavours: Rocket Root Beer and Charged Cream Soda - Barchart
Cannabis Extract Market Projected To Witness Massive Growth, 2025-2032 | Canopy Growth Corporation, Aurora - EIN News
Canopy Growth slips on earnings miss - Sherwood News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Canopy Growth CorporationCGC - PR Newswire
Canopy Growth’s stock falls to all-time low on pot company’s share-sale plans - MarketWatch
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More - Benzinga India
Canopy Growth Corporation - MENAFN.COM
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):